ARCHIVES

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

This article is from The Cancer Letter archive.

Vol. 05 No. 46 | November 16, 1979

Download PDF Visit The Full Archive

Related Articles

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

Spectral Mammography “Like Color vs. Black & White TV”

August 31, 2012

In Brief: Fauci, Washington Univ. Chancellor, Merck Chairman Reportedly On Final NIH Director List

August 25, 1989

NCI Could Fund Some Challenge Grants That Miss NIH Funding, Director Says

June 26, 2009

CCOPs Extended One Year While Waiting Evaluation

May 17, 1985

Zeneca Says NSABP Was Tardy In Reporting Uterine Cancer Deaths

June 24, 1994